Germany’s Dermatology Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 6% during the forecast period.
Germany has one of the most rapidly aging and shrinking populations in the world, even though immigration has been increasing since 2011 when the overall decline was observed. The key focus is on active aging so that an increasing share is healthy for a longer part of their life span. Anti-aging products are in demand due to the growing female aging population.
The major factor that contributes to the growth of the dermatological market includes a rise in demand for topical dermatological drugs such as anti-inflammatory agents, anti-infectives, local anesthetics, cleansers, and emollients to treat acne.
Increasing cases of dermatological diseases, the growing public awareness about these conditions, and the increasing aging population are driving the dermatological therapeutics market growth in Germany.
Other major factors which are affecting the German market alongside the global markets include the rising incidence of skin diseases, escalating disposable income, and a surging number of research programs.